Human Baculoviral IAP repeat-containing protein 3(BIRC3) ELISA kit

Code CSB-EL002704HU
Size 96T,5×96T,10×96T
Price Request a Quote or Start an on-line Chat
Trial Size 24T ELISA Kit Trial Size (Only USD$150/ kit)
* The sample kit cost can be deducted from your subsequent orders of 96T full size kits of the same analyte at 1/5 per kit, until depleted in 6 months. Apply now

Product Details

Target Name
baculoviral IAP repeat-containing 3
Alternative Names
AIP 1 ELISA Kit; AIP1 ELISA Kit; API 2 ELISA Kit; API2 ELISA Kit; Apoptosis inhibitor 2 ELISA Kit; Baculoviral IAP repeat containing 3 ELISA Kit; Baculoviral IAP repeat containing protein 3 ELISA Kit; Baculoviral IAP repeat-containing protein 3 ELISA Kit; BIRC 3 ELISA Kit; BIRC3 ELISA Kit; BIRC3_HUMAN ELISA Kit; C IAP2 ELISA Kit; C-IAP2 ELISA Kit; Cellular inhibitor of apoptosis 2 ELISA Kit; cellular inhibitor of apoptosis protein 2 ELISA Kit; CIAP 2 ELISA Kit; CIAP2 ELISA Kit; HAIP 1 ELISA Kit; HAIP1 ELISA Kit; HIAP 1 ELISA Kit; HIAP-1 ELISA Kit; HIAP1 ELISA Kit; IAP homolog C ELISA Kit; IAP-1 ELISA Kit; Inhibitor of apoptosis protein 1 ELISA Kit; MALT 2 ELISA Kit; MALT2 ELISA Kit; Mammalian IAP homolog C ELISA Kit; MIHC ELISA Kit; RING finger protein 49 ELISA Kit; RNF49 ELISA Kit; TNFR2 TRAF signaling complex protein 1 ELISA Kit; TNFR2 TRAF signalling complex protein ELISA Kit; TNFR2-TRAF-signaling complex protein 1 ELISA Kit
Abbreviation
BIRC3
Uniprot No.
Species
Homo sapiens (Human)
Sample Types
serum, plasma, tissue homogenates
Detection Range
37.5 pg/mL-2400 pg/mL
Sensitivity
9.4 pg/mL
Assay Time
1-5h
Sample Volume
50-100ul
Detection Wavelength
450 nm
Research Area
Cell Biology
Assay Principle
quantitative
Measurement
Sandwich
Precision
Intra-assay Precision (Precision within an assay): CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess.
Inter-assay Precision (Precision between assays): CV%<10%
Three samples of known concentration were tested in twenty assays to assess.
Linearity
To assess the linearity of the assay, samples were spiked with high concentrations of human BIRC3 in various matrices and diluted with the Sample Diluent to produce samples with values within the dynamic range of the assay.
  Sample Serum(n=4)
1:1 Average % 91
Range % 86-94
1:2 Average % 92
Range % 87-95
1:4 Average % 94
Range % 87-98
1:8 Average % 103
Range % 96-107
Recovery
The recovery of human BIRC3 spiked to levels throughout the range of the assay in various matrices was evaluated. Samples were diluted prior to assay as directed in the Sample Preparation section.
Sample Type Average % Recovery Range
Serum (n=5) 91 86-94
EDTA plasma (n=4) 103 98-107
Typical Data
These standard curves are provided for demonstration only. A standard curve should be generated for each set of samples assayed.
pg/ml OD1 OD2 Average Corrected
2400 2.154 2.274 2.214 2.112
1200 1.268 1.318 1.293 1.191
600 0.741 0.798 0.770 0.668
300 0.443 0.460 0.452 0.350
150 0.292 0.285 0.289 0.187
75 0.167 0.174 0.171 0.069
37.5 0.132 0.139 0.136 0.034
0 0.101 0.102 0.102  
Troubleshooting
and FAQs
Storage
Store at 2-8°C. Please refer to protocol.
Lead Time
3-5 working days after you place the order, and it takes another 3-5 days for delivery via DHL or FedEx
Description

This Human BIRC3 ELISA Kit was designed for the quantitative measurement of Human BIRC3 protein in serum, plasma, tissue homogenates. It is a Sandwich ELISA kit, its detection range is 37.5 pg/mL-2400 pg/mL and the sensitivity is 9.4 pg/mL.

Customer Reviews and Q&A

 Customer Reviews

There are currently no reviews for this product.

Submit a Review here

Target Background

Function
(From Uniprot)
Multi-functional protein which regulates not only caspases and apoptosis, but also modulates inflammatory signaling and immunity, mitogenic kinase signaling and cell proliferation, as well as cell invasion and metastasis. Acts as an E3 ubiquitin-protein ligase regulating NF-kappa-B signaling and regulates both canonical and non-canonical NF-kappa-B signaling by acting in opposite directions: acts as a positive regulator of the canonical pathway and suppresses constitutive activation of non-canonical NF-kappa-B signaling. The target proteins for its E3 ubiquitin-protein ligase activity include: RIPK1, RIPK2, RIPK3, RIPK4, CASP3, CASP7, CASP8, IKBKE, TRAF1, and BCL10. Acts as an important regulator of innate immune signaling via regulation of Toll-like receptors (TLRs), Nodlike receptors (NLRs) and RIG-I like receptors (RLRs), collectively referred to as pattern recognition receptors (PRRs). Protects cells from spontaneous formation of the ripoptosome, a large multi-protein complex that has the capability to kill cancer cells in a caspase-dependent and caspase-independent manner. Suppresses ripoptosome formation by ubiquitinating RIPK1 and CASP8.
Gene References into Functions
  1. High BIRC3 expression is associated with Oral squamous cell carcinoma. PMID: 29286141
  2. Results indicate that Pellino-1 contributes to lung oncogenesis through the overexpression of inhibitor of apoptosis protein 2 (cIAP2) and promotion of cell survival and chemoresistance. PMID: 27248820
  3. We show that BIRC3 has a unique role in facilitating glioma progression from low- to high-grade PMID: 27074575
  4. CIAP2 expression was elevated in human GBC tissues. PMID: 28295868
  5. destabilization of TRAF2 by miR-17 reduced the ability of TRAF2 to associate with cIAP2, resulting in the downregulation of TNF-alpha-induced NF-kappaBp65, c-Jun, and STAT3 nuclear translocation and the production of IL-6, IL-8, MMP-1, and MMP-13 in human rheumatoid arthritis synovial fibroblasts. PMID: 27534557
  6. The expression of cIAP2 mRNA was significantly higher in the groups with Helicobacter pylori(+), atrophic gastritis/intestinal metaplasia(+), and Helicobacter pylori-positive early gastric cancer than in the control, Helicobacter pylori(+), and atrophic gastritis/intestinal metaplasia(-) groups. PMID: 27282269
  7. Polymorphisms in the BIRC3 gene are associated with a protective effect with regards to asthma susceptibility, and a reduced load of inflammatory cells. PMID: 27304223
  8. we indicated that miR-34a can inhibit tumor invasion and metastasis in osteosarcoma, and its mechanism may be partly related to downregulating the expression of C-IAP2 and Bcl-2 protein directly or indirectly. PMID: 28635396
  9. Study demonstrate that BIRC3 expression increases secondary to acquisition of temozolomide TMZ and irradiation resistance in glioblastoma. PMID: 26888114
  10. High BIRC3 expression is associated with pancreatic cancer. PMID: 26815504
  11. Network analysis identified BIRC3 as pathogenic gene in childhood asthma. PMID: 27420950
  12. The clinical impact of small subclones harboring NOTCH1, SF3B1, or BIRC3 mutations in chronic lymphocytic leukemia patients appears to be less pronounced than that of small TP53 mutated subclones. PMID: 26819056
  13. cIAP2 is upregulated in regenerative epithelial cells both in ulcerative colitis and in experimental intestinal wounds. Inhibition of cIAP2 decreases wound healing in vitro possibly through inhibition of migration. [review] PMID: 26513451
  14. LapR cells possessed increased levels of 2 of the inhibitors of apoptosis (IAPs), survivin and c-IAP-2, which are reported to block caspase activation downstream of cytosolic cytochrome C release. PMID: 25692408
  15. API2-MALT1 induces paracaspase-mediated cleavage of the tumour suppressor protein LIMA1. PMID: 25569716
  16. this study candidates BIRC3 as one of the potentially useful predictive marker for discriminating patients with oesophageal and oesophagogastric junction adenocarcinoma who will most likely benefit from preoperative chemoradiotherapy. PMID: 26291056
  17. these results indicate that N. gonorrhoeae stimulation of human endocervical epithelial cells induces the release of cIAP2, an essential regulator of cell death and immune signaling. PMID: 26077759
  18. Cytoplasmic expression of HuR is associated with cIAP2 expression in OSCCs PMID: 23852810
  19. in 11q-deleted patients treated with first-line chemotherapy, ATM mutation rather than BIRC3 deletion and/or mutation identifies a subgroup with a poorer outcome. PMID: 24584352
  20. a number of genes not previously known to be affected by RUNX2 expression, in particular BIRC3, genes encoded on the mitochondrial genome, and several genes involved in bone and tooth formation. PMID: 24349465
  21. TNF-alpha induced apoptosis of gastric cancer cells via accelerated degradation of the inhibitor of apoptosis family members, CIAP2, XIAP, and survivin. PMID: 25513960
  22. cIAP2 is in conclusion a regulator of human intestinal wound healing through enhanced migration along with activation of Rac1 PMID: 25394657
  23. Data indicate that tumor necrosis factor inducible protein A20-mediated inhibitor of apoptosis protein-2 (cIAP-2) is important in endothelial cell resistance to tumor necrosis factor alpha (TNF-alpha)-induced apoptosis. PMID: 24595242
  24. Identification and function of the NIK IAP binding motif, which promotes c-IAP1-dependent ubiquitylation of NIK. PMID: 25246529
  25. Distinctive role of c-IAP2 as stabilizer of XIAP, which is likely involved in regulation of NFkappaB activation and apoptosis in GBM cells was determined. PMID: 24552816
  26. increased expression with progression of chronic myeloid leukaemia PMID: 24266799
  27. our study implicates RIP1 ubiquitination as a critical component of API2-MALT1-dependent lymphomagenesis PMID: 23770847
  28. BIRC3 gene mutation is associated with chronic lymphocytic leukemia. PMID: 23558524
  29. we present cIAP-2 as a novel inducer of platinum resistance in ovarian carcinoma cells, and suggest an axis beginning with an encounter between cisplatin and these cells, mediated sequentially by IL-6 and cIAP-2, resulting in cisplatin resistance PMID: 23052480
  30. The expression of C-IAP2 in hepatocellular carcinoma is associated with tumor recurrence and metastasis. PMID: 22820591
  31. Clonal evolution from lower to higher risk implicated the emergence of NOTCH1, SF3B1, and BIRC3 abnormalities in addition to TP53 and 11q22-q23 lesions in chronic lymphocytic leukemia. PMID: 23243274
  32. A novel role for cIAP2 in maintaining wild-type p53 levels by preventing both an NFkappaB-mediated increase and IKKalpha/-beta-dependent transcriptional and post-translational modifications of MDM2. PMID: 23032264
  33. study shows API2-MALT1 fusion oncoprotein induces proteolytic cleavage of NF-kappaB-inducing kinase (NIK); resulting deregulated NIK activity is associated with constitutive noncanonical NF-kappaB signaling, enhanced B cell adhesion and apoptosis resistance PMID: 21273489
  34. TRAF2 and cIAP2 are involved in TWEAK-induced MMP-9 production in fibroblast-like synoviocytes in rheumatoid arthritis. PMID: 21229359
  35. NF-kappaappaB, acting through two response elements, is required for estrogen receptor recruitment to an adjacent estrogen response element in the BIRC3 promoter. PMID: 22083956
  36. BIRC3 disruption is a common mechanism across marginal zone B-cell lymphomagenesis. PMID: 21881048
  37. our results suggest that CpG-induced protection may be mediated by c-IAP-2 through the calcium-activated JNK pathway PMID: 22068233
  38. cIAP2 may play an important role in Helicobacter pylori -induced gastric carcinogenesis PMID: 21963223
  39. we confirm that mRNA and protein levels for cIAP2 are highly up-regulated in breast cancer cells by E2 and cytokines PMID: 21152357
  40. These data reveal a novel mechanism for the inhibition of hepatitis B virus replication by cIAP2 via acceleration of the ubiquitin-proteasome-mediated decay of polymerase. PMID: 21865390
  41. API2-MALT1 fusion gene is a distinctive genetic aberration in MALT lymphomas, and is not present in diffuse large B cell lymphoma. PMID: 20079017
  42. Adenosine downregulated the expression of mRNAs and proteins for Bcl-X(L) and inhibitor of apoptosis protein 2 (IAP2) to directly inhibit caspase-3, -7, and -9, but upregulated the expression of mRNA and protein for DIABLO, an inhibitor of IAPs. PMID: 20063052
  43. Arsenic trioxide suppresses transcription of cIAP2 mRNA in NB-4 cells. PMID: 19763917
  44. These results support a role for Tax-dependent cIAP-2 expression in preventing the death of naturally infected CD8(+) cells and thereby in their clonal expansion in vivo. PMID: 20863547
  45. TTP can bind to the 2nd AU-rich elements of cIAP2 mRNA 3'UTR and destabilize cIAP2 mRNA by forming complexes with Dcp2 and Xrn1. PMID: 20691152
  46. Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells. PMID: 20576118
  47. cancer cell lines evade Smac mimetic-induced apoptosis by up-regulation of cIAP2, which although initially degraded, rebounds. cIAP2 is induced by TNFalpha via NF-kappaB and modulation of the NF-kappaB signal renders cells sensitive to Smac mimetics PMID: 20547836
  48. crystal structures of the TRAF2: cIAP2 and the TRAF1: TRAF2: cIAP2 complexes; biochemical, structural, and cell biological studies on the interaction between TRAF2 and cIAP2 and on the ability of TRAF1 to modulate this interaction PMID: 20385093
  49. Results provide the first structures of BIR domains from human NAIP and cIAP2. PMID: 19923725
  50. REVIEW: Genetic alterations involving API2 underlying the pathogenesis of MALT lymphoma PMID: 11960389

Show More

Hide All

Involvement in disease
A chromosomal aberration involving BIRC3 is recurrent in low-grade mucosa-associated lymphoid tissue (MALT lymphoma). Translocation t(11;18)(q21;q21) with MALT1. This translocation is found in approximately 50% of cytogenetically abnormal low-grade MALT lymphoma.
Subcellular Location
Cytoplasm. Nucleus.
Protein Families
IAP family
Tissue Specificity
Highly expressed in fetal lung, and kidney. In the adult, expression is mainly seen in lymphoid tissues, including spleen, thymus and peripheral blood lymphocytes.
Database Links

HGNC: 591

OMIM: 601721

KEGG: hsa:330

STRING: 9606.ENSP00000263464

UniGene: Hs.127799

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
7505 Fannin St., Ste 610, Room 7 (CUBIO Innovation Center), Houston, TX 77054, USA
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2024 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1